Miltefosine
(Redirected from Miltex)
Miltefosine is a pharmaceutical agent primarily prescribed for the treatment of leishmaniasis and specific free-living amoeba infections. Marketed under the brand name Impavido among other labels, this drug has revolutionized the treatment of some challenging parasitic diseases, particularly within the tropical disease domain.
Indications[edit | edit source]
Miltefosine has shown therapeutic benefits against a spectrum of parasitic infections:
Leishmaniasis: The drug combats all three clinical manifestations of this condition:
Free-Living Amoeba Infections:
- Naegleria fowleri: A rare, but often fatal, brain infection[3].
- Balamuthia mandrillaris: An amoeba that affects the skin and the central nervous system.
In certain scenarios or for particular patient demographics, Miltefosine might be prescribed alongside other antiparasitic treatments, such as liposomal amphotericin B or paromomycin.
Administration[edit | edit source]
Administered orally, Miltefosine offers a preferable alternative to the often cumbersome intravenous or intramuscular treatments generally prescribed for parasitic afflictions.
Mechanism of Action[edit | edit source]
While ongoing research is still demystifying its exact mechanism, existing evidence suggests that Miltefosine disrupts the cellular metabolism of parasites, halting their growth and proliferation[4].
Adverse Effects[edit | edit source]
Like many drugs, Miltefosine has associated side effects that can range from mild to severe:
Common:
- Vomiting
- Abdominal pain
- Fever
- Headaches
- Impaired kidney function
Severe:
- Stevens-Johnson syndrome: A severe dermatological reaction.
- Thrombocytopenia: A condition characterized by reduced blood platelet count[5].
Contraindications[edit | edit source]
Pregnant individuals should refrain from Miltefosine due to documented teratogenic effects on the fetus[6]. Lactating mothers should also avoid this medication due to the potential risk it poses to infants.
Conclusion[edit | edit source]
Miltefosine heralds a new era in the treatment of leishmaniasis and certain amoebic infections. As the medical landscape continues its evolution, the balance between this drug's therapeutic potential and its associated risks becomes ever more critical, ensuring both patient safety and effective outcomes.
References[edit | edit source]
- ↑ Sundar, S., & Chakravarty, J. (2015). Leishmaniasis: An update of current pharmacotherapy. Expert Opinion on Pharmacotherapy, 16(2), 237-252.
- ↑ Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R. W., ... & Boelaert, M. (2007). Visceral leishmaniasis: What are the needs for diagnosis, treatment, and control? Nature Reviews Microbiology, 5(11), S7-S16.
- ↑ Grace, E., Asbill, S., & Virga, K. (2015). Naegleria fowleri: Pathogenesis, diagnosis, and treatment options. Antimicrobial Agents and Chemotherapy, 59(11), 6677-6681.
- ↑ Dorlo, T. P., Balasegaram, M., Beijnen, J. H., & de Vries, P. J. (2012). Miltefosine: A review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. Journal of Antimicrobial Chemotherapy, 67(11), 2576-2597.
- ↑ Rijal, S., Ostyn, B., Uranw, S., Rai, K., Bhattarai, N. R., Dorlo, T. P., ... & Boelaert, M. (2013). Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clinical Infectious Diseases, 56(11), 1530-1538.
- ↑ Dorlo, T. P., Huitema, A. D., Beijnen, J. H., & de Vries, P. J. (2012). Optimal dosing of miltefosine in children and adults with visceral leishmaniasis. Antimicrobial Agents and Chemotherapy, 56(7), 3864-3872.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
- Antiprotozoal agents
- Antifungals
- Quaternary ammonium compounds
- Antiretroviral drugs
- Antineoplastic drugs
- Zwitterionic surfactants
- Protein kinase inhibitors
- Embryotoxicants
- Fetotoxicants
- Drugs acting on the blood and blood forming organs
- Antivirals
- German inventions
- World Health Organization essential medicines
- RTT
Contributors: Prab R. Tumpati, MD